J. Spies

发表

Autoregulation of cerebral blood flow in orthostatic hypotension.

P. Novak, V. Novak, P. Low, 1998, Stroke.

The clinical profile of NMOSD in Australia and New Zealand

K. Dear, S. Broadley, J. Lechner-Scott, 2020, Journal of Neurology.

Cerebrovascular Regulation in the Postural Orthostatic Tachycardia Syndrome (POTS)

P. Novak, V. Novak, P. Low, 1999 .

Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies

J. McArthur, P. Low, W. Singer, 2004, Neurology.

Gain and Loss of Gastrointestinal Symptoms in Diabetes Mellitus: Associations With Psychiatric Disease, Glycemic Control, and Autonomic Neuropathy over 2 Years of Follow-up

M. Horowitz, N. Talley, Michael P. Jones, 2008, The American Journal of Gastroenterology.

Myasthenia Gravis

J. Spies, P. Spring, 2012, BioDrugs.

Options and Timing of Immunomodulatory Treatment

J. Spies, P. Spring, 2001 .

Intraneural activated T cells cause focal breakdown of the blood-nerve barrier.

J. Pollard, J. Spies, K. Westland, 1995, Brain : a journal of neurology.

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation

S. Broadley, J. Lechner-Scott, M. Slee, 2020, Frontiers in Neurology.

Investigation of tumefactive demyelination is associated with higher economic burden and more adverse events compared with conventional multiple sclerosis.

M. Barnett, J. Spies, J. Barton, 2019, Multiple sclerosis and related disorders.

Severe hypertensive encephalopathy following percutaneous balloon aortic valvuloplasty for aortic stenosis.

M. Ng, J. Spies, B. Gray, 2014, International journal of cardiology.

Autosomal dominant hereditary sensory neuropathy with chronic cough and gastro-oesophageal reflux: clinical features in two families linked to chromosome 3p22-p24.

J. Pollard, G. Nicholson, J. Spies, 2005, Brain : a journal of neurology.

Clinical features of patients with Guillain‐Barré syndrome at seven hospitals on the East Coast of Australia

P. Mccombe, J. Spies, S. Blum, 2013, Journal of the peripheral nervous system : JPNS.

Management of Guillain-Barré syndrome

J. Spies, K. Sheikh, 2001, Expert review of neurotherapeutics.

Nerve biopsy: Current indications and decision tools

Min-Xia Wang, J. Pollard, C. Sommer, 2021, Muscle & nerve.

Conduction block in immune‐mediated neuropathy: paranodopathy versus axonopathy

J. Pollard, M. Barnett, C. Yiannikas, 2019, European journal of neurology.

Activated T cells of nonneural specificity open the blood‐nerve barrier to circulating antibody

H. Hartung, J. Pollard, K. Toyka, 1995, Annals of neurology.

Nerve biopsy in acquired neuropathies

G. Sobue, C. Sommer, M. Kiernan, 2021, Journal of the peripheral nervous system : JPNS.

Effective treatment of experimental autoimmune neuritis with human immunoglobulin

J. Pollard, J. Spies, Jun-lan Lu, 2007, Journal of the Neurological Sciences.

Vasculitis confined to peripheral nerves.

J. Mcleod, J. Pollard, J. Spies, 1996, Brain : a journal of neurology.

Killer immunoglobulin-like receptor and their HLA ligands in Guillain–Barré Syndrome

P. Mccombe, J. Spies, S. Blum, 2014, Journal of Neuroimmunology.

Effect of leflunomide on the peripheral nerves in rheumatoid arthritis

J. Spies, B. Richards, J. Vaile, 2007, Internal medicine journal.

Motor unit remodelling in multifocal motor neuropathy: The importance of axonal loss

J. Pollard, C. Yiannikas, M. Kiernan, 2017, Clinical Neurophysiology.

Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies

J. Pollard, M. Barnett, C. Yiannikas, 2017, Journal of Neuroimmunology.

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

G. L. Masson, C. Ervin, H. Hartung, 2018, The Lancet Neurology.

Cerebrovascular regulation in the postural orthostatic tachycardia syndrome (POTS).

P. Novak, V. Novak, P. Low, 1999, The American journal of the medical sciences.

Acute psychiatric illness in a young woman: an unusual form of encephalitis

S. Lewis, G. M. Halmágyi, J. Dalmau, 2009, The Medical journal of Australia.

Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedules.

M. Barnett, S. Adelstein, J. Spies, 2020, Multiple sclerosis and related disorders.

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

Jeffrey A. Cohen, Islam M. Zaydan, Gregory F. Wu, 2022, The Lancet Neurology.

A Flow Cytometric Assay to Detect Functional Ganglionic Acetylcholine Receptor Antibodies by Immunomodulation in Autoimmune Autonomic Ganglionopathy

K. Blazek, S. Adelstein, B. Lang, 2021, Frontiers in Immunology.

Tuberculous cranial pachymeningitis

M. Thurtell, J. Spies, T. Gottlieb, 2007, Neurology.

Isolated sixth cranial nerve palsy in preeclampsia.

M. Thurtell, J. Spies, G. Halmágyi, 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology

R. Freeman, A. Lipp, G. Wenning, 2020, Clinical Neurophysiology.

A Recurrent De Novo Nonsense Variant in ZSWIM6 Results in Severe Intellectual Disability without Frontonasal or Limb Malformations.

J. Rosenfeld, M. Shaw, J. Gécz, 2017, American journal of human genetics.

Vasculitic neuropathy: Comparison of clinical predictors with histopathological outcome

Min-Xia Wang, J. Pollard, M. Barnett, 2019, Muscle & nerve.

Differentiating lower motor neuron syndromes

J. Pollard, J. M. Matamala, M. Reilly, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations

S. Broadley, J. Lechner-Scott, M. Slee, 2014, Journal of Clinical Neuroscience.

Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: A case report and literature review

L. Horvath, G. Femia, J. Spies, 2012, Asia-Pacific journal of clinical oncology.

Acute Hemichorea‐Hemiballismus Following COVID‐19 (AZD1222) Vaccination

E. Matar, J. Spies, J. Worthington, 2021, Movement disorders : official journal of the Movement Disorder Society.

Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels

J. Pollard, C. Yiannikas, M. Kiernan, 2018, Clinical Neurophysiology.

Demyelinating neuropathies triggered by melanoma immunotherapy

G. Fuller, J. Pollard, J. Spies, 1994, Neurology.

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies

S. Broadley, J. Lechner-Scott, M. Slee, 2014, Journal of Clinical Neuroscience.

Myasthenia gravis: options and timing of immunomodulatory treatment.

J. Spies, P. Spring, 2001, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Significant dermatological side effects of intravenous immunoglobulin

C. Yiannikas, J. Spies, C. Hurelbrink, 2013, Journal of Clinical Neuroscience.

Corrigendum to “Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology” [Clin. Neurophysiol. 132(2) (2021) 666–682]

R. Freeman, A. Lipp, G. Wenning, 2021, Clinical Neurophysiology.

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis

S. Broadley, J. Lechner-Scott, M. Slee, 2021, Frontiers in Neurology.

Hypocapnia and cerebral hypoperfusion in orthostatic intolerance.

P. Novak, T. Rummans, V. Novak, 1998, Stroke.

Synergy between antibody and P2-reactive T cells in experimental allergic neuritis

J. Pollard, J. Spies, K. Westland, 1995, Journal of Neuroimmunology.

Autonomic Nervous System Disorders

J. Spies, Robert Henderson, Judy Spies, 2014, Hankey's Clinical Neurology.

Incidence and prevalence of NMOSD in Australia and New Zealand

K. Dear, S. Broadley, J. Lechner-Scott, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy

S. Broadley, J. Lechner-Scott, M. Slee, 2014, Journal of Clinical Neuroscience.

A new era in the treatment of multiple sclerosis

Jeannette Lechner-Scott, Helmut Butzkueven, John King, 2015, The Medical journal of Australia.

Effective treatment of experimental autoimmune neuritis with Fc fragment of human immunoglobulin

J. Pollard, J. Spies, Min Wang, 2007, Journal of Neuroimmunology.

004 Mechanisms of nerve dysfunction in inflammatory neuropathies

J. Pollard, C. Yiannikas, M. Kiernan, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

224. Charles bonnet syndrome caused by optic neuritis following immune desensitisation therapy for allergic rhinitis

J. Spies, J. Parratt, J. Burrell, 2009, Journal of Clinical Neuroscience.

Autoregulation of cerebral blood flow in orthostatic hypotension.

P. Novak, V. Novak, P. Low, 1998, Stroke.

Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy after mRNA COVID19 vaccination

J. Spies, Nicolás Urriola, Simon Rowe, 2022, Autoimmunity Reviews.

Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels

J. Pollard, C. Yiannikas, M. Kiernan, 2018, Clinical Neurophysiology.

Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies

J. Pollard, N. Yuki, C. Yiannikas, 2017, Journal of Neuroimmunology.

128 Late-onset pompe disease (LOPD) presenting with fulminant hypercapnic respiratory failure

B. Yee, J. Spies, M. Tchan, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.